. . . . "Resistance proportions across 924,635 Escherichia coli isolates from human urinary tract infections reported to the Dutch ISIS-AR surveillance system by 27 laboratories between 2009 and 2020, ranging from 3.2% for ceftazidime to 38.8% for amoxicillin or ampicillin. 82.0% of isolates came from general practices and 77.2% from female patients." . . . . "Resistance levels in human urinary Escherichia coli isolates" . . . . . . "evidence" . "high throughput evidence" . "Lapo Mughini-Gras" . "Anouk P. Meijs" . "Eelco Franz" . "2026-09-07T10:58:21Z"^^ . . . . . "Evidence: Resistance levels in human urinary Escherichia coli isolates" . . . . . . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAq/UT4mEO8sT0Co9F/EBYsf3anJLEeBH0q+JCXbo7FCo+FUXSnic/50bSY5InZoQXt6Qc9QvJgiCe3b/OUr12QqUCQhrofuvRjCusikunl0HFMTLohACpWjtpeq2BY4G/2Vb/EtcgSU7S8SACDt8IEM3UYwFki0HBw1aLbbbVddyIaS7W7dBDye50WuWV6Tt2n4B+fCAwLzLilR44rJom+K93GF2IGH20l83edBVMm7W1xuRwCglHmtu5aM3v3VZfxGoveZEbtMp8LsGFO0IaLOGKi072OocbNZQ08KWNrLLCWwAN79xjb9gKK75AmVcgmQDInqY9P9mBKo85zhxeBwIDAQAB" . "FK3BMjn+tP2FIt3rRwavQP5NwpI3A7i32kSammsS1pX6Y8L9RT8q/F8Hi/IOby7Doc/OvmfUXwhsMcTVR1IZ8ofwrvXY7KSE7ZDCl5zx+UID5sBFvLJoqWoYz968HVWf/BVloI8pgI+zHazh9nnyFLPOI5amtXcsNjJ7+7LhWVjSzq5QD08CwcmaR3kRo77xCizyQiRXpOl1LCor2UodIMJmPhybmZQWPtvwA7dcwp64XfOjjiGSVKWyxUc7xwVJaSsaoaVcdSxGLhkm70CzbDJynetjyXuGX1GLIApwqFXXJ1/o0gTzNxhQvQqr2saJSBd/bv5WS4NIQdJYZdhVwA==" . . . "ZonMw Bot" .